Business Description
Founded in 1993 and based in Taiyuan, China, Pacific Shuanglin Bio-pharmacy develops, manufactures, and sells a range of blood-derived medical products for both domestic and international markets. Its portfolio includes treatments such as human serum albumin, various immunoglobulins, clotting factors, and fibrinogen, which are used to treat or prevent serious conditions including rabies, hepatitis B, and tetanus. The company also provides consulting, trading, and technical services in the pharmaceutical and biotechnology sectors.
